U
MGNX icon

UBS’s MacroGenics MGNX Stock Holding History

UBS’s Portfolio MGNX Stock Details MGNX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q3 		$2.02M Sell
96,669
-20,379
-17% -$421K ﹤0.01% 2905
2014
Q2 		$2.54M Buy
117,048
+116,438
+19,088% +$2.45M ﹤0.01% 2644
2014
Q1 		$17K Sell
610
-253
-29% -$8.93K ﹤0.01% 8309
2013
Q4 		$23K Buy
+863
New +$22.6K ﹤0.01% 7966

Other funds holding MGNX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
BRC
Blue Ridge Capital New York $215M AUM
TGHSA
TPG Group Holdings (SBS) Advisors Fort Worth, Texas $10.1B AUM 22.58% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.14% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return
EAM
EverPoint Asset Management Stamford, Connecticut $5.38B AUM 21.45% 1-Year Est. Return
PCA
Private Capital Advisors Darien, Connecticut $1.14B AUM 48.66% 1-Year Est. Return

UBS's MGNX Position: Q3 2014 in Review

UBS reduced its MacroGenics (MGNX) stake by 17% in Q3 2014, selling an estimated $421K and leaving 96,669 shares worth $2.02M. The position accounts for ﹤0.01% of the portfolio, ranked #2905.

UBS first reported a position in MGNX in Q4 2013 and has held it in 4 quarters since. The position peaked at $2.54M in Q2 2014. 85 funds tracked by Wall St. Rank hold MGNX as of Q3 2014.

  • UBS held 96,669 shares of MacroGenics worth $2.02M as of Q3 2014.
  • UBS sold 20,379 MacroGenics shares in Q3 2014, an estimated $421K.
  • MacroGenics made up ﹤0.01% of UBS's portfolio in Q3 2014, its #2905 holding.
  • UBS first reported a position in MacroGenics in Q4 2013 and has held it in 4 quarters since.
  • UBS's MacroGenics position peaked at $2.54M in Q2 2014.
  • 85 funds tracked by Wall St. Rank held MacroGenics as of Q3 2014.

Based on UBS's 13F filing for Q3 2014, filed 12 Nov 2014.